ELAN - Elanco Animal Health Incorporated
Chart Events
Triple Moving Average Crossover
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 21.98 |
| Open | 22.91 |
| Bid | 22.69 x 800 |
| Ask | 22.70 x 800 |
| Day's Range | 22.08 - 23.30 |
| 52 Week Range | 15.17 - 35.46 |
| Volume | 2,220,983 |
| Avg. Volume | 6,565,860 |
| Market Cap | 9.138B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 127.39 |
| EPS (TTM) | 0.18 |
| Earnings Date | May 06, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 31.25 |
Fair Value
Related Research
- Business Wire
Elanco Confirms Date and Conference Call for First Quarter 2020 Financial Results Announcement
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2020 financial results on Thursday, May 7, 2020. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance.
- GlobeNewswire
The Elanco Foundation Announces Efforts to Support Food Security Amidst COVID-19 Crisis
Today, the recently-formed Elanco Foundation pledged more than $700,000 to help fight rising food insecurity challenges due to the novel coronavirus outbreak. The funds will support organizations and food banks in communities across Elanco Animal Health’s (ELAN) footprint, including Gleaners Food Bank of Indiana, the European Food Banks Federation and food banks in Winslow, Maine, Ft. Dodge, Iowa, Clinton, Ind., the Kansas City area, and Greenfield, Ind. communities. The Elanco Foundation will continue to monitor the emerging food security issues arising from the COVID-19 crisis in other regions of the globe.
- Investor's Business Daily
Fluffy's Drugmakers Are Insulated From Coronavirus — But For How Long?
The health of Fido and Fluffy is considered "essential" — which could shield animal-health player Zoetis from the near-term effects of the coronavirus outbreak, an analyst said Tuesday.
- Business Wire
Elanco Provides Business Update Related to COVID-19
As Elanco Animal Health Incorporated (NYSE: ELAN) evaluates the potential impact of the COVID-19 pandemic, it is providing an update on its business and financial position, as well as the actions it is taking to support employees, customers and public health.
- Insider Monkey
Were Hedge Funds Right About Dumping Elanco Animal Health (ELAN)?
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- Business Wire
Elanco to Participate in Cowen Health Care Conference
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Cowen and Company 40th Annual Health Care Conference on Wednesday, March 4, 2020, in Boston, Mass. Jeff Simmons, president and chief executive officer, will participate in a fireside chat at 9:20 a.m. Eastern Time.
- GuruFocus.com
Larry Robbins' Top 6 4th-Quarter Buys in Health Care
Guru establishes three new health care holdings, markets continue falling on coronavirus fears Continue reading...
- Business Wire
Elanco to Participate in the Bank of America Merrill Lynch Animal Health Summit
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Bank of America Merrill Lynch Animal Health Summit on Monday, Feb. 24, 2020, in New York, N.Y. Todd Young, executive vice president and CFO, will represent the company and respond to questions from analysts. He is scheduled to present at 3:05 p.m. ET.
- Business Wire
Elanco Signs Agreement with Merck Animal Health to Divest Worldwide Rights for Vecoxan®
Elanco Animal Health Incorporated (NYSE: ELAN) announced today it signed an agreement with Merck Animal Health (also known as MSD Animal Health) to divest worldwide rights for Vecoxan® for $55 million in an all-cash deal. Vecoxan® is used for prevention and treatment of coccidiosis in calves and lambs.
- Zacks
Elanco Animal Health Incorporated (ELAN) Q4 Earnings Match Estimates
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 0.00% and -0.50%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Elanco Animal Health Reports 2019 Fourth Quarter and Full Year Results
Elanco Animal Health Incorporated (NYSE: ELAN) today reported its financial results for the fourth quarter and full year of 2019, the first full year as an independent company. The full year 2019 results reflect the durability and agility of a fit-for-purpose dedicated animal health company driving growth in our Core business, excluding Strategic Exits, and improved profitability through execution of the company's productivity agenda.
- Reuters
Hormel joins Tyson Foods, JBS in removing drug banned by China from hog supply
Spam-maker Hormel Foods Corp is eliminating a growth drug banned by China from its hog supply, the company said on Tuesday, joining rivals that are seeking to increase meat sales to Chinese buyers grappling with a pork shortage. Hormel will not accept any hogs that have been fed or exposed to the drug ractopamine after April 1, the company said in a statement. Tyson Foods Inc and JBS USA said last year they would remove the drug from their supply chains.
- Business Wire
Elanco’s East Africa Growth Accelerator Delivers $8+ Million in Socio-Economic Value for Smallholder Farmers in East Africa, Progress Against Sustainable Development Goals
Elanco Animal Health Inc. (NYSE: ELAN) today announced that its shared value East Africa Growth Accelerator (EAGA) initiative has delivered a Social Return on Investment (SROI) of almost 250% for dairy and poultry smallholder farmers, their families and other stakeholders in the region. For every US$1 invested by Elanco and its partners in the EAGA initiative during its initial phase from June 2017 to December 2018, $2.48 of socio-economic value has been created for society in East Africa.
- Business Wire
Elanco Signs Agreement with Vetoquinol to Divest Rights for Drontal® and Profender® Within the European Economic Area and the United Kingdom
Elanco Animal Health Incorporated (NYSE: ELAN) announced today it has signed an agreement to divest the European Economic Area and UK rights to the Drontal® and Profender® product families from Bayer AG’s (ETR: BAYN) animal health business, to Vetoquinol SA (EURONEXT: VETO), a French pharmaceutical company, for $140 million in an all-cash deal subject to customary post-closing adjustments. Drontal and Profender are both de-wormers for dogs and cats.
- Zacks
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q4 Earnings Expected to Decline
Elanco Animal Health Incorporated (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
New Strong Sell Stocks for February 11th
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
- Kiplinger
The 9 Best 'Purebred' Pet Stocks to Buy
America's love affair with its pets is creating a booming pet care industry - and, as a result, a small but expanding cluster of pet stocks.Pet care might be bigger than you realize. Edge by Ascential, a market research firm, says that North American spending on pets hit $225 billion in 2018, and is expected to hit $281 billion by 2023 - roughly 5% compound annual growth. Millennials and Gen-Zers are embracing pet ownership in far greater numbers than previous generations; roughly two-thirds of U.S. households own a pet, up from 56% just 30 years ago.Rising demand is fueling a diverse set of pet stocks - companies that provide everything from premium kibble to medications to even pet DNA testing and health insurance.You can get some pet-related exposure among blue chips such as General Mills (GIS), which acquired all-natural pet-food leader Blue Buffalo for $8 billion in 2018. Aon (AON) boasts a top-rated pet insurance business in the form of subsidiary Healthy Paws; Synchrony Financial (SYF) bought a principal rival, Pet's Best, in 2019. However, pet care remains a small portion of their overall business.Here, we look at nine of the best pure-play pet stocks to buy right now. This is a mix of high-growth newcomers and a few more established plays. We'll start with a couple of well-known blue chips before making our way to some under-the-radar names. SEE ALSO: 64 Dividend Stocks You Can Count on in 2020
- Business Wire
Elanco Animal Health Announces Pricing and Upsize of Senior Secured Term Loan Facilities
Elanco Animal Health Incorporated (NYSE: ELAN) today announced that it successfully priced its first lien senior secured credit facilities consisting of (i) a term loan B facility in an aggregate principal amount of $4,275.0 million with a maturity of seven years and (ii) a revolving loan facility providing up to $750.0 million with a maturity of five years. The amount of the term loan B facility was upsized from the initial amount of $2,425.0 million due to market demand. The term loan B facility will be priced at par at LIBOR plus 175 basis points and the revolving loan facility is expected to bear interest at LIBOR plus an applicable margin ranging between 1.50% and 2.25% per annum based on Elanco’s corporate family rating or corporate credit rating.
- Business Wire
Elanco Animal Health Announces Strategic Alliance With Purdue University and Purdue Research Foundation
Elanco Animal Health Incorporated (NYSE: ELAN) today announced a four-year agreement with Purdue University and Purdue Research Foundation with the goal to collaborate and train talent, as Elanco seeks solutions to solve some of the greatest challenges in animal health.
- Zacks
Elanco (ELAN) Surges: Stock Moves 5.3% Higher
Elanco (ELAN) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
- Zacks
New Strong Sell Stocks for January 14th
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
